{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:09:38Z","timestamp":1779912578951,"version":"3.53.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,5,18]],"date-time":"2007-05-18T00:00:00Z","timestamp":1179446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11936-007-0011-8","type":"journal-article","created":{"date-parts":[[2007,5,18]],"date-time":"2007-05-18T05:52:02Z","timestamp":1179467522000},"page":"180-190","source":"Crossref","is-referenced-by-count":11,"title":["von Willebrand factor in CHD and stroke: Relationships and therapeutic implications"],"prefix":"10.1007","volume":"9","author":[{"given":"Marie-Therese","family":"Cooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Dudina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,18]]},"reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1055\/s-0037-1616143","volume":"86","author":"M.J. Hollestelle","year":"2001","unstructured":"Hollestelle MJ, Thinnes T, Crain K, et al.: Tissue distribution of factor VIII gene expression in vivo\u2014a closer look. Thromb Haemost 2001, 86:855\u2013861.","journal-title":"Thromb Haemost"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1172\/JCI119195","volume":"99","author":"Z.M. Ruggeri","year":"1997","unstructured":"Ruggeri ZM: von Willebrand factor. J Clin Invest 1997, 99:559\u2013564.","journal-title":"J Clin Invest"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1073\/pnas.82.24.8752","volume":"82","author":"K.M. Brinkhous","year":"1985","unstructured":"Brinkhous KM, Sandberg H, Garris JB, et al.: Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci U S A 1985, 82:8752\u20138756.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","volume":"6","author":"D.D. Wagner","year":"1990","unstructured":"Wagner DD: Cell biology of von Willebrand Factor. Annu Rev Cell Biol 1990, 6:217\u2013246.","journal-title":"Annu Rev Cell Biol"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1182\/blood.V93.12.4277","volume":"93","author":"A.M. Keightley","year":"1999","unstructured":"Keightley AM, Lam YM, Brady JN, et al.: Variation at the von Willebrand factor (vWF) gene locus is associated with plasm a vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 1999, 93:4277\u20134283.","journal-title":"Blood"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2141.2003.04776.x","volume":"124","author":"I.M. Meer der","year":"2004","unstructured":"der Meer IM, Brouwers GJ, Bulk S, et al.: Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study. Br J Haematol 2004, 124:343\u2013347.","journal-title":"Br J Haematol"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.STR.0000244767.39962.f7","volume":"37","author":"T.N. Bongers","year":"2006","unstructured":"Bongers TN, de Maat MP, van Goor ML, et al.: High von Willebrand factor levels increase the risk of first ischemic stroke, Influence of ADAMTS13, inflammation, and genetic variability. Stroke 2006, 37:2672\u20132677.","journal-title":"Stroke"},{"key":"11_CR8","first-page":"327","volume":"47","author":"S. Goto","year":"2001","unstructured":"Goto S: Role of von Willebrand factor for the onset of arterial thrombosis. Clin Lab 2001, 47:327\u2013334.","journal-title":"Clin Lab"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/beha.2001.0133","volume":"14","author":"Z. Ruggeri","year":"2001","unstructured":"Ruggeri Z: Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Pract Res Clin Haematol 2001, 14:257\u2013279.","journal-title":"Best Pract Res Clin Haematol"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1172\/JCI108985","volume":"61","author":"W. Fuster","year":"1978","unstructured":"Fuster W, Bowie EJ, Lewis JC, et al.: Resistance to arteriosclerosis in pigs with von Willebrand\u2019s disease, Spontaneous and high cholesterol diet-induced arteriosclerosis. J Clin Invest 1978, 61:722\u2013730.","journal-title":"J Clin Invest"},{"key":"11_CR11","first-page":"56","volume":"83","author":"T.C. Nichols","year":"1991","unstructured":"Nichols TC, Bellinger RL, Reddick MS, et al.: Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs. Circulation 1991, 83:56\u201364.","journal-title":"Circulation"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.CIR.96.4.1102","volume":"96","author":"A.R. Folsom","year":"1997","unstructured":"Folsom AR, Wu KK, Rosamond WD, et al.: Prospective study of markers of haemostatic function with risk of ischemic stroke: the Atherosclerotic Risk in Communities (ARIC) Study Investigators. Circulation 1997, 96:1102\u20131108.","journal-title":"Circulation"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.100.7.736","volume":"100","author":"A.R. Folsom","year":"1999","unstructured":"Folsom AR, Rosamond WD, Shahar E, et al.: Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation 1999, 100:736\u2013742.","journal-title":"Circulation"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00149831-200512000-00005","volume":"12","author":"P.A. O\u2019Callaghan","year":"2005","unstructured":"O\u2019Callaghan PA, Fitzgerald, Fogarty J, et al.: New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in Smokers. Eur J Cardiovasc Prev Rehabil 2005, 12:542\u2013547.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1161\/01.ATV.17.11.3321","volume":"17","author":"F.B. Smith","year":"1997","unstructured":"Smith FB, Lee AJ, Fowkes FGR, et al.: Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh artery study. Arterioscler Thromb Vasc Biol 1997, 17:3321\u20133325.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","volume":"350","author":"J. Danesh","year":"2004","unstructured":"Danesh J, Wheeler JG, Hirschfield GM, et al.: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387\u20131397.","journal-title":"N Engl J Med"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/euhj.2001.3237","volume":"23","author":"P.H. Whincup","year":"2002","unstructured":"Whincup PH, Danesh J, Walker M, et al.: von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 2002, 23:1764\u20131770.","journal-title":"Eur Heart J"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1161\/01.CIR.0000077912.12202.FC","volume":"107","author":"D.S. Conway","year":"2003","unstructured":"Conway DS, Pearce LA, Chin BS, et al.: Prognostic value of plasm a von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation 2003, 107:3141\u20133145.","journal-title":"Circulation"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","volume":"24","author":"R.M. Conroy","year":"2003","unstructured":"Conroy RM, Pyorala K, Fitzgerald AP, et al.: Estimation of ten years risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987\u20131003.","journal-title":"Eur Heart J"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/aje\/kwh189","volume":"160","author":"L. Chambless","year":"2004","unstructured":"Chambless L, Heiss G, Shahar E, et al.: Prediction of ischemic stroke in the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2004, 160:259\u2013269.","journal-title":"Am J Epidemiol"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1161\/CIRCULATIONAHA.105.557132","volume":"112","author":"A. Smith","year":"2005","unstructured":"Smith A, Patterson C, Yarnell J, et al.: Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke. Circulation 2005, 112:3080\u20133087.","journal-title":"Circulation"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"B.F. Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W, et al.: Validation of clinical classification schemes for predicting stroke, results from the National Registry of Atrial Fibrillation. JAMA 2001, 285:2864\u20132870.","journal-title":"JAMA"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.STR.0000236840.00467.84","volume":"37","author":"G.Y. Lip","year":"2006","unstructured":"Lip GY, Land D, Van Walraven C, Hart RG: Additive role of plasm a von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation stroke. Stroke 2006, 37:2294\u20132300.","journal-title":"Stroke"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.CIR.0000033220.97592.9A","volume":"106","author":"D.S.G. Conway","year":"2002","unstructured":"Conway DSG, Pearce LA, Chin BSP, et al.: Plasm a von Willebrand factor and soluble P-Selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation. Relationship to stroke risk factors. Circulation 2002, 106:1962\u20131967.","journal-title":"Circulation"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.CIR.0000083471.33820.3C","volume":"108","author":"J.P. Collet","year":"2003","unstructured":"Collet JP, Montalescot G, Vicaut E, et al.: Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality. Circulation 2003, 108:392\u2013394.","journal-title":"Circulation"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.CIR.98.4.294","volume":"98","author":"G. Montalescot","year":"1998","unstructured":"Montalescot G, Philippe F, Ankri A, et al.: Early increase of von Willebrand factor predicts adverse outcomes in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. Circulation 1998, 98:294\u2013299.","journal-title":"Circulation"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0735-1097(00)00695-1","volume":"361","author":"G. Montalescot","year":"2000","unstructured":"Montalescot G, Collet JP, Lison L, et al.: Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J Am Coll Cardiol 2000, 361:110\u2013114.","journal-title":"J Am Coll Cardiol"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2004-03-1106","volume":"105","author":"K.W. Lee","year":"2005","unstructured":"Lee KW, Lip GY, Tayebjee M, et al.: Circulating endothelial cells, von Willebrand factor, interleukin-6 and prognosis in patients with acute coronary syndromes. Blood 2005, 105:526\u2013532.","journal-title":"Blood"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1055\/s-0038-1656120","volume":"77","author":"A.J. Catto","year":"1997","unstructured":"Catto AJ, Carter AM, Barrett JH, et al.: von Willebrand factor and factor VIIIc in acute cerebrovascular disease: relationship to stroke subtype and mortality. Thromb Haemost 1997, 77:1104\u20131108.","journal-title":"Thromb Haemost"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/0735-1097(90)92845-S","volume":"15","author":"J.H. Ip","year":"1990","unstructured":"Ip JH, Fuster V, Badimon L, et al.: Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990, 15:1667\u20131687.","journal-title":"J Am Coll Cardiol"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"19L","DOI":"10.1016\/S0002-9149(98)00108-8","volume":"82","author":"M. Cohen","year":"1998","unstructured":"Cohen M, Demers C, Gurfinkel EP, et al.: Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events. Am J Cardiol 1998, 82:19L\u201324L.","journal-title":"Am J Cardiol"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-007-0011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-007-0011-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-007-0011-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T04:40:33Z","timestamp":1587530433000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-007-0011-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,18]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s11936-007-0011-8","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,18]]}}}